Keebeck Alpha »

Cerevel Therapeutics Hldng I shares owned by Keebeck Alpha

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Keebeck Alpha from 13F filings

Historical chart of Keebeck Alpha investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Keebeck Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Keebeck Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 47k 42.40

More positions owned by Keebeck Alpha

American Equity Investment Life Holding (AEL)
stock
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Karuna Therapeutics Ord
Amedisys (AMED)
ImmunoGen
Hess (HES)
Sovos Brands
Pioneer Natural Resources (PXD)
Capstar Finl Hldgs (CSTR)
Neogames S A SHS (NGMS)
Capri Holdings SHS (CPRI)
Ishares Tr Russell 2000 Etf (IWM)
Consolidated Communications Holdings (CNSL)

View all positions for Keebeck Alpha

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I